OLIVIA LAMONTAGNE: Open Payments
NPI 1689435513 · CICERO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,313 in 71 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $463 · 2025 $1,313
Food & beverage: $1,313
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $189 |
| ABBVIE INC. | 8 | $180 |
| Lilly USA, LLC | 8 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $145 |
| AstraZeneca Pharmaceuticals LP | 8 | $145 |
| Axsome Therapeutics, Inc. | 4 | $66 |
| Lundbeck LLC | 3 | $55 |
| PFIZER INC. | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
Products named: CAPLYTA, JARDIANCE, AIRSUPRA, VRAYLAR, MOUNJARO, Ozempic, Wegovy, Auvelity.
Industry payments across NY — which companies pay providers there.
